Opebacan
- Generic Name
- Opebacan
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 206254-79-7
- Unique Ingredient Identifier
- 4X9EPQ6FMA
- Indication
Investigated for use/treatment in crohn's disease, congenital anomaly (unspecified), cardiovascular disorders, pediatric indications, and burns and burn infections.
- Associated Conditions
- -
- Associated Therapies
- -
Study of Opebacan in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
- First Posted Date
- 2007-03-30
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- XOMA (US) LLC
- Target Recruit Count
- 6
- Registration Number
- NCT00454155
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath